Skip to main content
Fig. 2 | Molecular Cancer

Fig. 2

From: Immunotherapies in rare cancers

Fig. 2

CAR-T cells mediating their anti-tumor effects. CAR-T cells require trafficking to the tumor cell surface so that they may bind to the target molecule to mediate anti-tumor effects. The main targets include immune checkpoints, chemokine-receptor network, tumor vasculature, and immune suppressive cells and cytokines (Fig. 2B-F)

Back to article page

Molecular Cancer

ISSN: 1476-4598